Suchergebnisse - Thomas, Alissa
- Treffer 1 - 20 von 24
- Zur nächsten Seite
-
1
Essential competencies in palliative medicine for neuro-oncologists von Thomas, Alissa A., Carver, Alan
Veröffentlicht 2015Text -
2
Immunotherapy for the Treatment of Glioblastoma von Thomas, Alissa A., Ernstoff, Marc S., Fadul, Camilo E.
Veröffentlicht 2012Text -
3
-
4
Vaccine-based immunotherapy for glioblastoma von Thomas, Alissa A, Fisher, Jan L, Ernstoff, Marc S, Fadul, Camilo E
Veröffentlicht 2013Text -
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
CLRM-13 RELEVANCE OF RECURSIVE PARTITIONING ANALYSIS (RPA) CLASSIFICATION IN THE CURRENT CARE OF PATIENTS WITH BRAIN METASTASES (BMETS) von Sarai, Guneet, Amidon, Ryan F, Bovi, Joesph A, Thomas, Alissa A, Novicoff, Wendy, Schuetz, Samantha, Singh, Rohit, Chang, Amy, Sheehan, Jason P, Fadul, Camilo E
Veröffentlicht 2022Text -
15
Large-volume low apparent diffusion coefficient lesions predict poor survival in bevacizumab-treated glioblastoma patients von Zhang, Myron, Gulotta, Bryanna, Thomas, Alissa, Kaley, Thomas, Karimi, Sasan, Gavrilovic, Igor, Woo, Kaitlin M., Zhang, Zhigang, Arevalo-Perez, Julio, Holodny, Andrei I., Rosenblum, Marc, Young, Robert J.
Veröffentlicht 2016Text -
16
Cancer Care in the Wake of a Cyberattack: How to Prepare and What to Expect von Ades, Steven, Herrera, Diego Adrianzen, Lahey, Tim, Thomas, Alissa A., Jasra, Sakshi, Barry, Maura, Sprague, Julian, Dittus, Kim, Plante, Timothy B., Kelly, Jamie, Kaufman, Peter A., Khan, Farrah, Hammond, Cory J., Gernander, Kelly, Parsons, Polly, Holmes, Chris
Veröffentlicht 2022Text -
17
SNO 2020 diversity survey: defining demographics, racial biases, career success metrics and a path forward for the field of neuro-oncology von Chukwueke, Ugonma N, Vera, Elizabeth, Acquaye, Alvina, Hervey-Jumper, Shawn L, Odia, Yazmin, Klesse, Laura J, Dunbar, Erin, Sharma, Akanksha, Fonkem, Ekokobe, Thomas, Alissa A, Werbowetski-Ogilvie, Tamra E, Camelo-Piragua, Sandra, Gatson, Na Tosha N, de la Fuente, Macarena I, Armstrong, Terri S, Porter, Alyx B, Jackson, Sadhana
Veröffentlicht 2021Text -
18
Regulatory T cells are not a strong predictor of survival for patients with glioblastoma von Thomas, Alissa A., Fisher, Jan L., Rahme, Gilbert J., Hampton, Thomas H., Baron, Udo, Olek, Sven, Schwachula, Tim, Rhodes, C. Harker, Gui, Jiang, Tafe, Laura J., Tsongalis, Gregory J., Lefferts, Joel A., Wishart, Heather, Kleen, Jonathan, Miller, Michael, Whipple, Chery A., de Abreu, Francine B., Ernstoff, Marc S., Fadul, Camilo E.
Veröffentlicht 2015Text -
19
Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma von Grommes, Christian, Tang, Sarah S., Wolfe, Julia, Kaley, Thomas J., Daras, Mariza, Pentsova, Elena I., Piotrowski, Anna F., Stone, Jacqueline, Lin, Andrew, Nolan, Craig P., Manne, Malbora, Codega, Paolo, Campos, Carl, Viale, Agnes, Thomas, Alissa A., Berger, Michael F., Hatzoglou, Vaios, Reiner, Anne S., Panageas, Katherine S., DeAngelis, Lisa M., Mellinghoff, Ingo K.
Veröffentlicht 2019Text -
20
COVD-31. THE STATE OF NEURO-ONCOLOGY DURING THE COVID-19 PANDEMIC: A WORLDWIDE ASSESSMENT von Mrugala, Maciej, Ostrom, Quinn, Pressley, Shelley, Thomas, Alissa, Wefel, Jeffrey S, Coven, Scott, Acquaye, Alvina, Haynes, Chas, Agnihotri, Sameer, Lim, Michael, Peters, Katherine, Butowski, Nicholas, Hervey-Jumper, Shawn, Porter, Alyx, Oliver, Kathy, Dunbar, Erin, Taylor, Jennie, Schiff, David, Nassiri, Farshad, Hegi, Monika, Armstrong, Terri, van den Bent, Martin, Chang, Susan, Zadeh, Gelareh, Chheda, Milan
Veröffentlicht 2020Text